Molecular Pharmacology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
Department of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.
J Dig Dis. 2020 Aug;21(8):430-436. doi: 10.1111/1751-2980.12918.
Inflammasomes have become an important natural sensor of host immunity, and can protect various organs against pathogenic infections, metabolic syndromes, cellular stress and cancer metastasis. Inflammasomes are intracellular multi-protein complexes found in both parenchymal and non-parenchymal cells, stimulating the initiation of caspase-1 and interleukin (IL)-1β and IL-18 in response to cell danger signals. Inflammasomes induce cell death mechanisms. The potential role of NOD-like receptor protein 3 (NLRP3) inflammasome in alcoholic and non-alcoholic steatohepatitis, hepatitis, nanoparticle-induced liver injury and other liver diseases has recently attracted widespread attention from clinicians and researchers. In this review we summarize the role played by the NLRP3 inflammasome in molecular and pathophysiological mechanisms in the pathogenesis and progression of liver disease. This article aims to establish that targeting the NLRP3 inflammasome and other inflammasome components may make a significant therapeutic approach to the treatment of liver disease.
炎症小体已成为宿主免疫的重要天然传感器,能够保护各种器官免受病原感染、代谢综合征、细胞应激和癌症转移的侵害。炎症小体是存在于实质细胞和非实质细胞中的细胞内多蛋白复合物,可在细胞危险信号的刺激下,启动半胱氨酸蛋白酶-1(caspase-1)和白细胞介素(IL)-1β和 IL-18 的产生。炎症小体诱导细胞死亡机制。NOD 样受体蛋白 3(NLRP3)炎症小体在酒精性和非酒精性脂肪性肝炎、肝炎、纳米颗粒诱导的肝损伤和其他肝病中的潜在作用,最近引起了临床医生和研究人员的广泛关注。在这篇综述中,我们总结了 NLRP3 炎症小体在肝病发病机制和进展中的分子和病理生理学机制中的作用。本文旨在确定靶向 NLRP3 炎症小体和其他炎症小体成分可能成为治疗肝病的一种重要治疗方法。